Institutional implementation of clinical tumor profiling on an unselected cancer population
Lynette M. Sholl(Brigham and Women's Hospital), Laura E. MacConaill(Brigham and Women's Hospital), Alice H. Berger(Fred Hutch Cancer Center), Priyanka Shivdasani(Brigham and Women's Hospital), Phani K. Davineni(Brigham and Women's Hospital), James M. Cleary(Brigham and Women's Hospital), Shakti Ramkissoon(Foundation Medicine (United States)), Matthew D. Ducar(Brigham and Women's Hospital), Adrian M. Dubuc(University of Toronto), Neal I. Lindeman(Cornell University), Ryan Abo(Brigham and Women's Hospital), Azra H. Ligon(Brigham and Women's Hospital), Marian H. Harris(Boston Children's Hospital), Geoffrey I. Shapiro(Brigham and Women's Hospital), Geoffrey R. Oxnard(Foundation Medicine (United States)), Alanna J. Church(Boston Children's Hospital), Aaron R. Thorner(Center for Cancer Research), Bruce E. Johnson(Harvard University), Levi A. Garraway(Broad Institute), Katherine A. Janeway(Harvard University), Matthew Meyerson(Broad Institute), Philip W. Kantoff(Convergent Science (United States)), Joshua D. Campbell(Broad Institute), Ursula A. Matulonis(Dana-Farber Cancer Institute), Vanessa Tassell(Pfizer (United States)), Barrett J. Rollins(Brigham and Women's Hospital), William C. Hahn(Broad Institute), Frank C. Kuo(Brigham and Women's Hospital), Mizuki Nishino(Brigham and Women's Hospital), Lauren L. Ritterhouse(Brigham and Women's Hospital), Ethan Cerami, Trevor J. Pugh(Boston Children's Hospital), James G. Christensen, T. Khanh(Brigham and Women's Hospital), Vanesa Rojas‐Rudilla(Brigham and Women's Hospital), Richard C. Chao(Mirati Therapeutics (United States)), David J. Kwiatkowski(Brigham and Women's Hospital), Yonghui Jia(Brigham and Women's Hospital), Elizabeth P. Garcia(Brigham and Women's Hospital), Paul Van Hummelen
Cited by 447
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
|New England Journal of Medicine|2010|5.5k